Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Steroids for Early Treatment of Radiation Retinopathy

NCT03238157 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT03238157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03238157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Steroids for Early Treatment of Radiation Retinopathy
Lead sponsor
The Cleveland Clinic
Phase
Phase 2/3
Overall status
Withdrawn
Start date
February 1, 2022
Completion date
September 1, 2022
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

radiation retinopathy